Published in Contraception on May 31, 2016
Residence Time of Biomarkers of Semen Exposure | NCT00984555
The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature (2003) 12.44
Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol (2009) 2.57
Prostate-specific antigen to ascertain reliability of self-reported coital exposure to semen. Sex Transm Dis (2006) 2.31
Efficacy of the female condom as a barrier to semen during intercourse. Am J Epidemiol (2003) 2.20
Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure. Contraception (1999) 2.18
Validity of self-reported 'safe sex' among female sex workers in Mombasa, Kenya--PSA analysis. Int J STD AIDS (2007) 2.03
Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA. Contraception (2013) 1.68
Postcoital detection of a male-specific semen protein. Application to the investigation of rape. N Engl J Med (1985) 1.44
Biological validation of self-reported condom use among sex workers in Guinea. AIDS Behav (2009) 1.34
Objective markers of condom failure. Sex Transm Dis (1998) 1.30
Using objective markers to assess participant behavior in HIV prevention trials of vaginal microbicides. J Acquir Immune Defic Syndr (2008) 1.26
Isolation and characterization of a semen-specific protein from human seminal plasma: a potential new marker for semen identification. J Forensic Sci (1978) 1.26
Condom use and vaginal Y-chromosome detection: the specificity of a potential biomarker. Sex Transm Dis (2007) 1.25
Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV. Contraception (2007) 1.19
Effectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: a randomized trial. Contraception (2005) 1.16
Polymerase chain reaction detection of Y-chromosome sequences in vaginal fluid of women accessing a sexually transmitted disease clinic. Sex Transm Dis (2006) 1.13
Biomarkers of semen exposure. Sex Transm Dis (2009) 1.12
Polymerase chain reaction detection of Y chromosome sequences in vaginal fluid: preliminary studies of a potential biomarker for sexual behavior. Sex Transm Dis (2005) 1.12
Prostate-specific antigen in vaginal fluid after exposure to known amounts of semen and after condom use: comparison of self-collected and nurse-collected samples. Hum Reprod (2008) 1.10
Detection and quantification of Y-chromosomal sequences by real-time PCR using the LightCycler system. Sex Transm Dis (2007) 1.05
Effect of menses on clearance of Y-chromosome in vaginal fluid: implications for a biomarker of recent sexual activity. Sex Transm Dis (2010) 1.02
Structure and function of TSPY, the Y-chromosome gene coding for the "testis-specific protein". Cytogenet Cell Genet (1998) 0.99
Detection of Y chromosome DNA as evidence of semen in cervicovaginal secretions of sexually active women. Clin Diagn Lab Immunol (2001) 0.97
Effectiveness of the male latex condom: combined results for three popular condom brands used as controls in randomized clinical trials. Contraception (2004) 0.94
Evaluation of semen detection in vaginal secretions: comparison of four methods. Am J Reprod Immunol (2008) 0.94
Evaluation of prostate-specific antigen as a quantifiable indicator of condom failure in clinical trials. Contraception (1999) 0.93
Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards. Contraception (2012) 0.92
An enzyme immunoassay for prostate-specific p30 antigen detection in the postcoital vaginal tract. J Forensic Sci Soc (1989) 0.88
Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance. Contraception (2012) 0.87
Use of prostate-specific antigen (PSA) to measure semen exposure resulting from male condom failures: implications for contraceptive efficacy and the prevention of sexually transmitted disease. Contraception (2003) 0.87
Improving second-generation surveillance: the biological measure of unprotected intercourse using prostate-specific antigen in vaginal secretions of West African women. J Acquir Immune Defic Syndr (2006) 0.86
Critical next steps for female condom research--report from a workshop. Contraception (2009) 0.84
Real-time quantitative polymerase chain reaction measurement of male fetal DNA in maternal plasma. Methods Mol Med (2007) 0.80
TSPY4 is a novel sperm-specific biomarker of semen exposure in human cervicovaginal fluids; potential use in HIV prevention and contraception studies. Contraception (2012) 0.78